A1339 - 2′-FL, 3-FL, LNT, 3′-SL, and 6′-SL from GM Escherichia coli BL21 for use as nutritive substances in infant formula products

This application seeks to permit the voluntary use of 2′-FL, 3-FL, LNT, 3′-SL, and 6′-SL, alone or in combination, as nutritive substances in infant formula products. The nutritive substance ingredients are derived from various genetically modified Escherichia coli BL21 strains.

Consultation and assessment

Call for submissions

This application is being assessed under FSANZ’s general procedure and will include one round of public consultation. The current call for submissions will run from 23 January to 6 March 2026.

• A1339 Call for submissions (693 KB)
• A1339 Supporting document (1 MB)
• A1339 Application (2.4 MB)

Submissions can be made on the A1339 Consultation Hub page.

Administrative Assessment

• A1339 Administrative Assessment Report (191 KB)

• A1339 Executive Summary (196 KB)